[go: up one dir, main page]

DK0746334T3 - Farmaceutisk præparat indeholdende plasminogenaktivatorer - Google Patents

Farmaceutisk præparat indeholdende plasminogenaktivatorer

Info

Publication number
DK0746334T3
DK0746334T3 DK95910500T DK95910500T DK0746334T3 DK 0746334 T3 DK0746334 T3 DK 0746334T3 DK 95910500 T DK95910500 T DK 95910500T DK 95910500 T DK95910500 T DK 95910500T DK 0746334 T3 DK0746334 T3 DK 0746334T3
Authority
DK
Denmark
Prior art keywords
pct
plasminogen activators
pharmaceutical preparation
preparation containing
containing plasminogen
Prior art date
Application number
DK95910500T
Other languages
English (en)
Inventor
Heinrich Woog
Ulrich Kohnert
Stephan Fischer
Hans-Joerg Markl
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK0746334T3 publication Critical patent/DK0746334T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95910500T 1994-02-21 1995-02-18 Farmaceutisk præparat indeholdende plasminogenaktivatorer DK0746334T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4405426A DE4405426A1 (de) 1994-02-21 1994-02-21 Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate
PCT/EP1995/000596 WO1995022347A1 (de) 1994-02-21 1995-02-18 Pharmazeutisches präparat enthaltend plasminogenaktivatoren

Publications (1)

Publication Number Publication Date
DK0746334T3 true DK0746334T3 (da) 2001-12-27

Family

ID=6510724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95910500T DK0746334T3 (da) 1994-02-21 1995-02-18 Farmaceutisk præparat indeholdende plasminogenaktivatorer

Country Status (26)

Country Link
US (1) US5747030A (da)
EP (1) EP0746334B1 (da)
JP (1) JP3868997B2 (da)
KR (1) KR100356934B1 (da)
CN (1) CN1170591C (da)
AT (1) ATE205091T1 (da)
AU (1) AU691881B2 (da)
BR (1) BR9506840A (da)
CA (1) CA2183755C (da)
CZ (1) CZ286682B6 (da)
DE (2) DE4405426A1 (da)
DK (1) DK0746334T3 (da)
ES (1) ES2162913T3 (da)
FI (1) FI117925B (da)
HU (1) HU219769B (da)
MX (1) MX9603515A (da)
NO (1) NO317726B1 (da)
NZ (1) NZ281607A (da)
PL (1) PL181257B1 (da)
PT (1) PT746334E (da)
RU (1) RU2155067C2 (da)
SG (1) SG50567A1 (da)
SK (1) SK282827B6 (da)
TW (1) TW337997B (da)
WO (1) WO1995022347A1 (da)
ZA (1) ZA951371B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702680D0 (sv) * 1997-07-11 1997-07-11 Astra Pharma Prod New formulation
US6653062B1 (en) * 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US9309316B2 (en) 2005-12-20 2016-04-12 Bristol-Myers Squibb Company Stable subcutaneous protein formulations and uses thereof
CA2634547C (en) 2005-12-20 2016-10-11 Bristol-Myers Squibb Company Stable ctla4 formulation for subcutaneous administration
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
EA037906B1 (ru) 2013-03-15 2021-06-04 Биовератив Терапьютикс Инк. Препараты полипептида фактора ix
SG10201913735SA (en) * 2014-03-24 2020-03-30 Bioverativ Therapeutics Inc Lyophilized factor ix formulations
BE1025996A9 (fr) * 2018-01-19 2020-05-11 Hyloris Dev Sa Solution orale d’acide tranexamique
US10980757B2 (en) * 2018-09-06 2021-04-20 RTU Pharma SA Ready-to-use tranexamic acid intravenous solution
JP2023537106A (ja) * 2020-08-10 2023-08-30 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 組織プラスミノーゲンアクティベーター製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3718889A1 (de) * 1987-06-05 1988-12-22 Behringwerke Ag Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942144A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von k1k2p pro
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung

Also Published As

Publication number Publication date
HUT74843A (en) 1997-02-28
EP0746334A1 (de) 1996-12-11
CZ243196A3 (en) 1997-01-15
JPH09511495A (ja) 1997-11-18
AU1758195A (en) 1995-09-04
DE59509580D1 (de) 2001-10-11
AU691881B2 (en) 1998-05-28
PT746334E (pt) 2002-02-28
SG50567A1 (en) 1998-07-20
NO317726B1 (no) 2004-12-13
SK107996A3 (en) 1997-04-09
HU9602284D0 (en) 1996-10-28
NO963460L (no) 1996-10-18
HU219769B (hu) 2001-07-30
FI963251A0 (fi) 1996-08-20
CA2183755C (en) 2004-02-17
RU2155067C2 (ru) 2000-08-27
US5747030A (en) 1998-05-05
CN1170591C (zh) 2004-10-13
NO963460D0 (no) 1996-08-20
KR100356934B1 (ko) 2003-02-26
ES2162913T3 (es) 2002-01-16
SK282827B6 (sk) 2002-12-03
CZ286682B6 (en) 2000-06-14
FI963251L (fi) 1996-08-20
PL181257B1 (pl) 2001-06-29
WO1995022347A1 (de) 1995-08-24
CN1141592A (zh) 1997-01-29
PL315978A1 (en) 1996-12-23
MX9603515A (es) 1997-03-29
JP3868997B2 (ja) 2007-01-17
FI117925B (fi) 2007-04-30
ZA951371B (en) 1996-08-20
TW337997B (en) 1998-08-11
ATE205091T1 (de) 2001-09-15
EP0746334B1 (de) 2001-09-05
BR9506840A (pt) 1997-10-14
CA2183755A1 (en) 1995-08-24
NZ281607A (en) 1997-04-24
DE4405426A1 (de) 1995-08-24
KR970701059A (ko) 1997-03-17

Similar Documents

Publication Publication Date Title
ATE205091T1 (de) Pharmazeutisches präparat enthaltend plasminogenaktivatoren
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
AU610636B2 (en) Stabilised human protein preparations
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
AU5795586A (en) Sterilant compositions
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
MY103943A (en) Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical compositions containing it
MY102929A (en) Aqueous pharmaceutical formulations of piroxicam monohydrate
DK304288D0 (da) Fremgangsmaade til fremstilling af en oploesning med hoej specifik rumgangsaktivitet af et protein med vaevs-plasmino-genaktivator (t-pa)-aktivitet og anvendelse af en oploesning, der indeholder protein med t-pa-aktivitet
SE9300105D0 (sv) Stable protein solution
ATE205399T1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
ES2132430T3 (es) Derivados de la quinolonilcarboxamidocefalosporina y composiciones farmaceuticas que los contienen.
NO20003888L (no) Anti-enzympreparater omfattende etylendiamindiravsyre
DE59005128D1 (de) t-PA pro STABILISIERUNG.
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
AU2357992A (en) Use of combination of a gel and a solution both containing an organic acid for cleaning dentures